SINGAPORE, July 23, 2024 /PRNewswire/ -- QDX, a computational drug discovery company, today announced a collaboration with Prelude Therapeutics, a clinical-stage precision oncology company, targeting ...

San Marcos, TX and High Point, NC, July 28, 2020 (GLOBE NEWSWIRE) -- QDX HealthID Incorporated, a wholly-owned subsidiary of Quantum Materials Corp (OTC Bulletin Board: QTMM) – today announced that in ...

QDX is a computational drug discovery company integrating quantum mechanical simulations, supercomputing, and artificial intelligence. By developing new systems and algorithms from ground up and ...

SINGAPORE, Nov. 26, 2024 /PRNewswire/ -- QDX proudly announces that the team led by its co-founder, Associate Professor Giuseppe Barca, has been honoured with the 2024 ACM Gordon Bell Prize, often ...